Effect of Coadministration of Moxifloxacin and Rifampin on Mycobacterium tuberculosis in a Murine Aerosol Infection Model

Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commerc...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Antimicrobial Agents and Chemotherapy 2012-06, Vol.56 (6), p.3054-3057
Hauptverfasser: BALASUBRAMANIAN, V, SOLAPURE, S, GANGULY, Samit, LOUIE, A, DRUSANO, G. L, GAONKAR, S, KUMAR, K. N. Mahesh, SHANDIL, R. K, DESHPANDE, Abhijeet, KUMAR, Naveen, VISHWAS, K. G, PANDUGA, Vijender, REDDY, Jitendar
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 3057
container_issue 6
container_start_page 3054
container_title Antimicrobial Agents and Chemotherapy
container_volume 56
creator BALASUBRAMANIAN, V
SOLAPURE, S
GANGULY, Samit
LOUIE, A
DRUSANO, G. L
GAONKAR, S
KUMAR, K. N. Mahesh
SHANDIL, R. K
DESHPANDE, Abhijeet
KUMAR, Naveen
VISHWAS, K. G
PANDUGA, Vijender
REDDY, Jitendar
description Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy AAC RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0066-4804 Online ISSN: 1098-6596 Copyright © 2014 by the American Society for Microbiology.   For an alternate route to AAC .asm.org, visit: AAC       
doi_str_mv 10.1128/AAC.06383-11
format Article
fullrecord <record><control><sourceid>proquest_highw</sourceid><recordid>TN_cdi_highwire_asm_aac_56_6_3054</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1020847911</sourcerecordid><originalsourceid>FETCH-LOGICAL-a507t-d61382c19ab9ce15bafb7febd94dff17cb76c234aaf81e7412085bb7f1ed3e5e3</originalsourceid><addsrcrecordid>eNp1kUFv1DAQhS0EotvCjTMKB6QikeKJEye5IK1WBSp1hYTgbE2ccddVYi92At1_j7e7FDhwssbz6T0_P8ZeAL8AKJp3y-XqgkvRiBzgEVsAb5tcVq18zBacS5mXDS9P2GmMtzzNVcufspOiKGsO0CzY7tIY0lPmTbby2I_W2TgFnKx3-7u1v7Nm8HeorcvQ9dkXa3DcpiHt1zvtO9QTBTuP2TR3FPQ8-Ghjtqez9Ryso2xJwUc_ZFdu77QXXvuehmfsicEh0vPjeca-fbj8uvqUX3_-eLVaXudY8XrKewmiKTS02LWaoOrQdLWhrm_L3hiodVdLXYgS0TRAdQkFb6ouIUC9oIrEGXt_0N3O3Ui9JpfyDWob7Ihhpzxa9e_G2Y268T-UEDWvC5EEzo8CwX-fKU5qtFHTMKAjP0cFPFmWdQuQ0LcHVKfIMZB5sAGu9m2p1Ja6b0vd428OOMaxULd-Di79xP_Yl3_HeBD-XWUCXh8BjBoHE9BpG_9wVXpgCTJxrw7cxt5sftpAKrkrRK0qqaQSvCrFL9-it9s</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1020847911</pqid></control><display><type>article</type><title>Effect of Coadministration of Moxifloxacin and Rifampin on Mycobacterium tuberculosis in a Murine Aerosol Infection Model</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>BALASUBRAMANIAN, V ; SOLAPURE, S ; GANGULY, Samit ; LOUIE, A ; DRUSANO, G. L ; GAONKAR, S ; KUMAR, K. N. Mahesh ; SHANDIL, R. K ; DESHPANDE, Abhijeet ; KUMAR, Naveen ; VISHWAS, K. G ; PANDUGA, Vijender ; REDDY, Jitendar</creator><creatorcontrib>BALASUBRAMANIAN, V ; SOLAPURE, S ; GANGULY, Samit ; LOUIE, A ; DRUSANO, G. L ; GAONKAR, S ; KUMAR, K. N. Mahesh ; SHANDIL, R. K ; DESHPANDE, Abhijeet ; KUMAR, Naveen ; VISHWAS, K. G ; PANDUGA, Vijender ; REDDY, Jitendar</creatorcontrib><description>Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions &amp; Commercial Reprints ASM Journals Public Access Policy AAC RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0066-4804 Online ISSN: 1098-6596 Copyright © 2014 by the American Society for Microbiology.   For an alternate route to AAC .asm.org, visit: AAC       </description><identifier>ISSN: 0066-4804</identifier><identifier>EISSN: 1098-6596</identifier><identifier>DOI: 10.1128/AAC.06383-11</identifier><identifier>PMID: 22470118</identifier><identifier>CODEN: AACHAX</identifier><language>eng</language><publisher>Washington, DC: American Society for Microbiology</publisher><subject>Aerosols ; Animal models ; Animals ; Antagonism ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Antitubercular Agents ; Antitubercular Agents - administration &amp; dosage ; Antitubercular Agents - pharmacokinetics ; Antitubercular Agents - therapeutic use ; Aza Compounds ; Aza Compounds - administration &amp; dosage ; Aza Compounds - pharmacokinetics ; Aza Compounds - therapeutic use ; Biological and medical sciences ; Colonies ; Experimental Therapeutics ; Fluoroquinolones ; Infection ; Lung ; Medical sciences ; Mice ; Mice, Inbred BALB C ; Moxifloxacin ; Mycobacterium tuberculosis ; Mycobacterium tuberculosis - drug effects ; Mycobacterium tuberculosis - pathogenicity ; Oral administration ; Pharmacodynamics ; Pharmacology. Drug treatments ; Quinolines ; Quinolines - administration &amp; dosage ; Quinolines - pharmacokinetics ; Quinolines - therapeutic use ; Replication ; Rifampin ; Rifampin - administration &amp; dosage ; Rifampin - pharmacokinetics ; Rifampin - therapeutic use ; Tuberculosis ; Tuberculosis, Pulmonary ; Tuberculosis, Pulmonary - drug therapy ; Tuberculosis, Pulmonary - microbiology</subject><ispartof>Antimicrobial Agents and Chemotherapy, 2012-06, Vol.56 (6), p.3054-3057</ispartof><rights>2015 INIST-CNRS</rights><rights>Copyright © 2012, American Society for Microbiology. All Rights Reserved.</rights><rights>Copyright © 2012, American Society for Microbiology. All Rights Reserved. 2012 American Society for Microbiology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a507t-d61382c19ab9ce15bafb7febd94dff17cb76c234aaf81e7412085bb7f1ed3e5e3</citedby><cites>FETCH-LOGICAL-a507t-d61382c19ab9ce15bafb7febd94dff17cb76c234aaf81e7412085bb7f1ed3e5e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3370723/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3370723/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=25911416$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22470118$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>BALASUBRAMANIAN, V</creatorcontrib><creatorcontrib>SOLAPURE, S</creatorcontrib><creatorcontrib>GANGULY, Samit</creatorcontrib><creatorcontrib>LOUIE, A</creatorcontrib><creatorcontrib>DRUSANO, G. L</creatorcontrib><creatorcontrib>GAONKAR, S</creatorcontrib><creatorcontrib>KUMAR, K. N. Mahesh</creatorcontrib><creatorcontrib>SHANDIL, R. K</creatorcontrib><creatorcontrib>DESHPANDE, Abhijeet</creatorcontrib><creatorcontrib>KUMAR, Naveen</creatorcontrib><creatorcontrib>VISHWAS, K. G</creatorcontrib><creatorcontrib>PANDUGA, Vijender</creatorcontrib><creatorcontrib>REDDY, Jitendar</creatorcontrib><title>Effect of Coadministration of Moxifloxacin and Rifampin on Mycobacterium tuberculosis in a Murine Aerosol Infection Model</title><title>Antimicrobial Agents and Chemotherapy</title><addtitle>Antimicrob Agents Chemother</addtitle><addtitle>Antimicrob Agents Chemother</addtitle><description>Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions &amp; Commercial Reprints ASM Journals Public Access Policy AAC RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0066-4804 Online ISSN: 1098-6596 Copyright © 2014 by the American Society for Microbiology.   For an alternate route to AAC .asm.org, visit: AAC       </description><subject>Aerosols</subject><subject>Animal models</subject><subject>Animals</subject><subject>Antagonism</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Antitubercular Agents</subject><subject>Antitubercular Agents - administration &amp; dosage</subject><subject>Antitubercular Agents - pharmacokinetics</subject><subject>Antitubercular Agents - therapeutic use</subject><subject>Aza Compounds</subject><subject>Aza Compounds - administration &amp; dosage</subject><subject>Aza Compounds - pharmacokinetics</subject><subject>Aza Compounds - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Colonies</subject><subject>Experimental Therapeutics</subject><subject>Fluoroquinolones</subject><subject>Infection</subject><subject>Lung</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>Mice, Inbred BALB C</subject><subject>Moxifloxacin</subject><subject>Mycobacterium tuberculosis</subject><subject>Mycobacterium tuberculosis - drug effects</subject><subject>Mycobacterium tuberculosis - pathogenicity</subject><subject>Oral administration</subject><subject>Pharmacodynamics</subject><subject>Pharmacology. Drug treatments</subject><subject>Quinolines</subject><subject>Quinolines - administration &amp; dosage</subject><subject>Quinolines - pharmacokinetics</subject><subject>Quinolines - therapeutic use</subject><subject>Replication</subject><subject>Rifampin</subject><subject>Rifampin - administration &amp; dosage</subject><subject>Rifampin - pharmacokinetics</subject><subject>Rifampin - therapeutic use</subject><subject>Tuberculosis</subject><subject>Tuberculosis, Pulmonary</subject><subject>Tuberculosis, Pulmonary - drug therapy</subject><subject>Tuberculosis, Pulmonary - microbiology</subject><issn>0066-4804</issn><issn>1098-6596</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kUFv1DAQhS0EotvCjTMKB6QikeKJEye5IK1WBSp1hYTgbE2ccddVYi92At1_j7e7FDhwssbz6T0_P8ZeAL8AKJp3y-XqgkvRiBzgEVsAb5tcVq18zBacS5mXDS9P2GmMtzzNVcufspOiKGsO0CzY7tIY0lPmTbby2I_W2TgFnKx3-7u1v7Nm8HeorcvQ9dkXa3DcpiHt1zvtO9QTBTuP2TR3FPQ8-Ghjtqez9Ryso2xJwUc_ZFdu77QXXvuehmfsicEh0vPjeca-fbj8uvqUX3_-eLVaXudY8XrKewmiKTS02LWaoOrQdLWhrm_L3hiodVdLXYgS0TRAdQkFb6ouIUC9oIrEGXt_0N3O3Ui9JpfyDWob7Ihhpzxa9e_G2Y268T-UEDWvC5EEzo8CwX-fKU5qtFHTMKAjP0cFPFmWdQuQ0LcHVKfIMZB5sAGu9m2p1Ja6b0vd428OOMaxULd-Di79xP_Yl3_HeBD-XWUCXh8BjBoHE9BpG_9wVXpgCTJxrw7cxt5sftpAKrkrRK0qqaQSvCrFL9-it9s</recordid><startdate>20120601</startdate><enddate>20120601</enddate><creator>BALASUBRAMANIAN, V</creator><creator>SOLAPURE, S</creator><creator>GANGULY, Samit</creator><creator>LOUIE, A</creator><creator>DRUSANO, G. L</creator><creator>GAONKAR, S</creator><creator>KUMAR, K. N. Mahesh</creator><creator>SHANDIL, R. K</creator><creator>DESHPANDE, Abhijeet</creator><creator>KUMAR, Naveen</creator><creator>VISHWAS, K. G</creator><creator>PANDUGA, Vijender</creator><creator>REDDY, Jitendar</creator><general>American Society for Microbiology</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7T7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>P64</scope><scope>5PM</scope></search><sort><creationdate>20120601</creationdate><title>Effect of Coadministration of Moxifloxacin and Rifampin on Mycobacterium tuberculosis in a Murine Aerosol Infection Model</title><author>BALASUBRAMANIAN, V ; SOLAPURE, S ; GANGULY, Samit ; LOUIE, A ; DRUSANO, G. L ; GAONKAR, S ; KUMAR, K. N. Mahesh ; SHANDIL, R. K ; DESHPANDE, Abhijeet ; KUMAR, Naveen ; VISHWAS, K. G ; PANDUGA, Vijender ; REDDY, Jitendar</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a507t-d61382c19ab9ce15bafb7febd94dff17cb76c234aaf81e7412085bb7f1ed3e5e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Aerosols</topic><topic>Animal models</topic><topic>Animals</topic><topic>Antagonism</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Antitubercular Agents</topic><topic>Antitubercular Agents - administration &amp; dosage</topic><topic>Antitubercular Agents - pharmacokinetics</topic><topic>Antitubercular Agents - therapeutic use</topic><topic>Aza Compounds</topic><topic>Aza Compounds - administration &amp; dosage</topic><topic>Aza Compounds - pharmacokinetics</topic><topic>Aza Compounds - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Colonies</topic><topic>Experimental Therapeutics</topic><topic>Fluoroquinolones</topic><topic>Infection</topic><topic>Lung</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>Mice, Inbred BALB C</topic><topic>Moxifloxacin</topic><topic>Mycobacterium tuberculosis</topic><topic>Mycobacterium tuberculosis - drug effects</topic><topic>Mycobacterium tuberculosis - pathogenicity</topic><topic>Oral administration</topic><topic>Pharmacodynamics</topic><topic>Pharmacology. Drug treatments</topic><topic>Quinolines</topic><topic>Quinolines - administration &amp; dosage</topic><topic>Quinolines - pharmacokinetics</topic><topic>Quinolines - therapeutic use</topic><topic>Replication</topic><topic>Rifampin</topic><topic>Rifampin - administration &amp; dosage</topic><topic>Rifampin - pharmacokinetics</topic><topic>Rifampin - therapeutic use</topic><topic>Tuberculosis</topic><topic>Tuberculosis, Pulmonary</topic><topic>Tuberculosis, Pulmonary - drug therapy</topic><topic>Tuberculosis, Pulmonary - microbiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>BALASUBRAMANIAN, V</creatorcontrib><creatorcontrib>SOLAPURE, S</creatorcontrib><creatorcontrib>GANGULY, Samit</creatorcontrib><creatorcontrib>LOUIE, A</creatorcontrib><creatorcontrib>DRUSANO, G. L</creatorcontrib><creatorcontrib>GAONKAR, S</creatorcontrib><creatorcontrib>KUMAR, K. N. Mahesh</creatorcontrib><creatorcontrib>SHANDIL, R. K</creatorcontrib><creatorcontrib>DESHPANDE, Abhijeet</creatorcontrib><creatorcontrib>KUMAR, Naveen</creatorcontrib><creatorcontrib>VISHWAS, K. G</creatorcontrib><creatorcontrib>PANDUGA, Vijender</creatorcontrib><creatorcontrib>REDDY, Jitendar</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Antimicrobial Agents and Chemotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>BALASUBRAMANIAN, V</au><au>SOLAPURE, S</au><au>GANGULY, Samit</au><au>LOUIE, A</au><au>DRUSANO, G. L</au><au>GAONKAR, S</au><au>KUMAR, K. N. Mahesh</au><au>SHANDIL, R. K</au><au>DESHPANDE, Abhijeet</au><au>KUMAR, Naveen</au><au>VISHWAS, K. G</au><au>PANDUGA, Vijender</au><au>REDDY, Jitendar</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of Coadministration of Moxifloxacin and Rifampin on Mycobacterium tuberculosis in a Murine Aerosol Infection Model</atitle><jtitle>Antimicrobial Agents and Chemotherapy</jtitle><stitle>Antimicrob Agents Chemother</stitle><addtitle>Antimicrob Agents Chemother</addtitle><date>2012-06-01</date><risdate>2012</risdate><volume>56</volume><issue>6</issue><spage>3054</spage><epage>3057</epage><pages>3054-3057</pages><issn>0066-4804</issn><eissn>1098-6596</eissn><coden>AACHAX</coden><abstract>Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions &amp; Commercial Reprints ASM Journals Public Access Policy AAC RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0066-4804 Online ISSN: 1098-6596 Copyright © 2014 by the American Society for Microbiology.   For an alternate route to AAC .asm.org, visit: AAC       </abstract><cop>Washington, DC</cop><pub>American Society for Microbiology</pub><pmid>22470118</pmid><doi>10.1128/AAC.06383-11</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0066-4804
ispartof Antimicrobial Agents and Chemotherapy, 2012-06, Vol.56 (6), p.3054-3057
issn 0066-4804
1098-6596
language eng
recordid cdi_highwire_asm_aac_56_6_3054
source MEDLINE; EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects Aerosols
Animal models
Animals
Antagonism
Antibiotics. Antiinfectious agents. Antiparasitic agents
Antitubercular Agents
Antitubercular Agents - administration & dosage
Antitubercular Agents - pharmacokinetics
Antitubercular Agents - therapeutic use
Aza Compounds
Aza Compounds - administration & dosage
Aza Compounds - pharmacokinetics
Aza Compounds - therapeutic use
Biological and medical sciences
Colonies
Experimental Therapeutics
Fluoroquinolones
Infection
Lung
Medical sciences
Mice
Mice, Inbred BALB C
Moxifloxacin
Mycobacterium tuberculosis
Mycobacterium tuberculosis - drug effects
Mycobacterium tuberculosis - pathogenicity
Oral administration
Pharmacodynamics
Pharmacology. Drug treatments
Quinolines
Quinolines - administration & dosage
Quinolines - pharmacokinetics
Quinolines - therapeutic use
Replication
Rifampin
Rifampin - administration & dosage
Rifampin - pharmacokinetics
Rifampin - therapeutic use
Tuberculosis
Tuberculosis, Pulmonary
Tuberculosis, Pulmonary - drug therapy
Tuberculosis, Pulmonary - microbiology
title Effect of Coadministration of Moxifloxacin and Rifampin on Mycobacterium tuberculosis in a Murine Aerosol Infection Model
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T11%3A33%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_highw&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20Coadministration%20of%20Moxifloxacin%20and%20Rifampin%20on%20Mycobacterium%20tuberculosis%20in%20a%20Murine%20Aerosol%20Infection%20Model&rft.jtitle=Antimicrobial%20Agents%20and%20Chemotherapy&rft.au=BALASUBRAMANIAN,%20V&rft.date=2012-06-01&rft.volume=56&rft.issue=6&rft.spage=3054&rft.epage=3057&rft.pages=3054-3057&rft.issn=0066-4804&rft.eissn=1098-6596&rft.coden=AACHAX&rft_id=info:doi/10.1128/AAC.06383-11&rft_dat=%3Cproquest_highw%3E1020847911%3C/proquest_highw%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1020847911&rft_id=info:pmid/22470118&rfr_iscdi=true